Breakpoint Cluster Region (BCR) (pTyr360) Peptide
BCR
Reactivité: Humain, Souris, Rat, Singe
Hôte: Synthetic
BP
-
- Antigène Tous les produits BCR
- BCR (Breakpoint Cluster Region (BCR))
- Protein Region
- pTyr360
- Origine
- Humain, Souris, Rat, Singe
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Attributs du produit
- The peptide is used to block Anti-BCR (pY360) Antibody reactivity.
-
-
- Indications d'application
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Stock
- -20 °C
- Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year.
- Date de péremption
- 12 months
-
- Antigène
- BCR (Breakpoint Cluster Region (BCR))
- Synonymes
- si:dkey-83d9.7 Peptide, zK83D9.7 Peptide, BCR Peptide, ALL Peptide, BCR1 Peptide, CML Peptide, D22S11 Peptide, D22S662 Peptide, PHL Peptide, 5133400C09Rik Peptide, AI561783 Peptide, AI853148 Peptide, mKIAA3017 Peptide, breakpoint cluster region Peptide, BCR, RhoGEF and GTPase activating protein Peptide, bcr Peptide, BCR Peptide, Bcr Peptide
- Sujet
- BCR1, D22S11, Breakpoint cluster region protein, Renal carcinoma antigen NY-REN-26
- ID gène
- 613, 110279
- UniProt
- P11274, Q6PAJ1
-
Vous êtes ici:
